Key result
Psyllium shows therapeutic potential for preventing and treating cardiometabolic diseases.
Answers are grounded in this paper and cite their sources.
Cardiometabolic diseases are reaching epidemic proportions worldwide. Dietary fiber intake can improve the risk factors associated with CMD. Psyllium, especially its husk, is one of the most widely used dietary fiber supplements, which is often used to enrich cereals and other food products. Numerous pharmacological studies have investigated the active ingredients and therapeutic effects of psyllium and its extracts, including antioxidant, anti-tumor, antidiabetic, hypotensive, anti-inflammation, neuroprotection, antidiarrheal, and antiviral activities. In this review, we will summarize the available studies on the therapeutic potential and possible mechanisms of psyllium in treating CMDs, such as hyperlipidemia, diabetes mellitus, and its complications, hypertension, hyperuricemia and obesity, and its applications in food systems.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2022) conducted a review in Cardiometabolic diseases (hyperlipidemia, diabetes mellitus, hypertension, hyperuricemia, obesity). Psyllium (dietary fiber supplement) was evaluated on Prevention and treatment of cardiometabolic diseases. Psyllium demonstrates therapeutic potential for preventing and treating cardiometabolic diseases, though no quantitative effect sizes are reported in this review.
Synapse has enriched 10 related papers. Consider them for comparative context: